These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9848433)

  • 21. Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapy.
    Reikvam A; Kvan E; Aursnes I
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):451-6. PubMed ID: 12652115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug therapy in angina pectoris].
    Follath F
    Praxis (Bern 1994); 1995 Oct; 84(42):1186-9. PubMed ID: 7481332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of pharmacological treatment on mortality after myocardial infarction in diabetic patients.
    Zuanetti G; Latini R
    J Diabetes Complications; 1997; 11(2):131-6. PubMed ID: 9101399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment after myocardial infarction].
    Beurrier D; Danchin N
    Presse Med; 1994 Feb; 23(8):380-4. PubMed ID: 7911570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA; Lauzon C; Eisenberg MJ; Huynh T; Dion D; Roux R; Racine N; Carignan S; Diodati JG; Charbonneau F; Lévesque C; Pouliot J J; Pilote L L
    Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful implementation of guidelines for encouraging the use of beta blockers in patients after acute myocardial infarction.
    Sarasin FP; Maschiangelo ML; Schaller MD; Héliot C; Mischler S; Gaspoz JM
    Am J Med; 1999 May; 106(5):499-505. PubMed ID: 10335720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues.
    Underwood P; Beck P
    Qual Saf Health Care; 2002 Sep; 11(3):230-2. PubMed ID: 12486986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of myocardial infarction.
    Timmis GC; Terrien E
    J Interv Cardiol; 1995 Dec; 8(6 Suppl):730-51. PubMed ID: 10159764
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in the management of acute myocardial infarction in Southern Tasmania.
    McNamara KS; Peterson GM; Friesen WT
    J Clin Pharm Ther; 2000 Apr; 25(2):111-8. PubMed ID: 10849188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment at discharge after myocardial infarction in 2,102 patients. The PRIMA study. Prise en charge de l'Infarctus du Myocarde Aigu.
    Excoffier S; De Gevigney G; Ecochard R; Rabilloud M; Cao D; Cheneau E; Milon H; Delahaye F
    Acta Cardiol; 2001 Feb; 56(1):17-26. PubMed ID: 11315120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of postmyocardial infarction in the elderly patient.
    Forman R; Aronow WS
    Clin Geriatr Med; 1996 Feb; 12(1):169-80. PubMed ID: 8653656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive medical therapy for acute myocardial infarction.
    Mancuso GM; Vacek JL; Forker AD
    Postgrad Med; 1994 Mar; 95(4):97-102, 109. PubMed ID: 7907177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
    Birdane A; Ata N
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance.
    McCormick D; Gurwitz JH; Savageau J; Yarzebski J; Gore JM; Goldberg RJ
    J Gen Intern Med; 1999 Feb; 14(2):73-81. PubMed ID: 10051777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.